Werner Kroll - May 27, 2022 Form 4 Insider Report for QuidelOrtho Corp (QDEL)

Role
SVP, Research and Development
Signature
/s/ Phillip S. Askim, attorney-in-fact for Werner Kroll
Stock symbol
QDEL
Transactions as of
May 27, 2022
Transactions value $
$0
Form type
4
Date filed
6/1/2022, 05:45 PM
Previous filing
Feb 14, 2022
Next filing
Jul 6, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QDEL Common Stock Award +18.8K 18.8K May 27, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QDEL Non-Qualified Stock Options Award $0 +2.3K $0.00 2.3K May 27, 2022 Common Stock 2.3K $46.41 Direct F2, F3
transaction QDEL Non-Qualified Stock Options Award $0 +3.92K $0.00 3.92K May 27, 2022 Common Stock 3.92K $59.12 Direct F2, F4
transaction QDEL Restricted Stock Units Award $0 +3.93K $0.00 3.93K May 27, 2022 Common Stock 3.93K Direct F5, F6, F7
transaction QDEL Restricted Stock Units Award $0 +2.74K $0.00 2.74K May 27, 2022 Common Stock 2.74K Direct F5, F6, F8
transaction QDEL Restricted Stock Units Award $0 +823 $0.00 823 May 27, 2022 Common Stock 823 Direct F5, F6, F8
transaction QDEL Restricted Stock Units Award $0 +4.27K $0.00 4.27K May 27, 2022 Common Stock 4.27K Direct F5, F6, F9
transaction QDEL Restricted Stock Units Award $0 +1.96K $0.00 1.96K May 27, 2022 Common Stock 1.96K Direct F5, F6, F10
transaction QDEL Restricted Stock Units Award $0 +2.63K $0.00 2.63K May 27, 2022 Common Stock 2.63K Direct F5, F6, F11
transaction QDEL Restricted Stock Units Award $0 +3.51K $0.00 3.51K May 27, 2022 Common Stock 3.51K Direct F5, F6, F12
transaction QDEL Restricted Stock Units Award $0 +10.6K $0.00 10.6K May 27, 2022 Common Stock 10.6K Direct F5, F6, F13
transaction QDEL Restricted Stock Units Award $0 +7.26K $0.00 7.26K May 27, 2022 Common Stock 7.26K Direct F5, F6, F14
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for one share of common stock of QuidelOrtho.
F2 Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options were converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).
F3 Vested in full.
F4 5,888 shares are vested in full; 1,962 shares will vest on February 4, 2023.
F5 Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.
F6 Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).
F7 3,925 shares will vest on February 4, 2023.
F8 Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.
F9 4,268 shares will vest on February 4, 2023.
F10 1,962 shares will vest in equal installments on July 1, 2022 and July 1, 2023.
F11 1,312 shares will vest on February 1, 2023; and 1,313 shares will vest on February 1, 2024.
F12 3,510 shares will vest in equal installments on July 28, 2022, July 28, 2023 and July 28, 2024.
F13 3,547 shares will vest on each of January 31, 2023 and January 31, 2024; 3,548 shares will vest on January 31, 2025.
F14 3,628 shares will vest on January 31, 2024; the remaining 3,628 shares will vest in equal installments on January 31, 2025 and January 31, 2026.

Remarks:

SVP, Research and Development